SUMMARY The hypothalamic-pituitary-adrenocortical axis was studied in 10 infants before and during a six week period of treatment with adrenocorticotrophic hormone (ACTH) and three days and one and two weeks after its stopping. During the treatment 24 hour urinary cortisol excretion increased 20 to 350-fold 
Treatment with adrenocorticotrophic hormone (ACTH) is believed to suppress the hypothalamicpituitary-adrenocortical axis far less than treatment with pharmacologic glucocorticoid.1 Serum cortisol responses to vasopressin test are often abnormal during treatment with ACTH,2-4 but impaired adrenocortical responsiveness to ACTH has not been reported after such treatment. A high dose course of ACTH lasting several weeks is commonly given to infants suffering from infantile spasms.5 Complications, even fatal ones, are common after such treatment. 6 We assessed the state of the hypothalamic-pituitary-adrenocortical axis before and after such treatment and found reduced adrenocortical responsiveness to ACTH.
Patients and methods
Our series comprised 10 infants admitted to this hospital over a 24 month period for infantile spasms. Their ages on admission were 5-22 (mean 9) months and their weights 6-1-12-2 (8.9) kg. Long acting carboxymethyl-cellulose ACTH (Acortan prolongatum, Ferring, Malmo, Sweden) was given intramuscularly every morning, 80 IU (6-6 to 13-1, mean 9-5 IU/kg) during weeks 1-3 and 40 IU during weeks 4 and 5, with tapering during and stopping at the end of week 6. Blood samples were drawn at 0800h (before injection of ACTH) and 24 
Results
Twenty four hour urinary cortisol excretion increased massively to a mean that was 100 times greater than the mean pretreatment excretion of 6-5 nmol/kg (Fig. 1) . The mean morning serum cortisol concentrations, measured 24 hours after the preceding ACTH dose, did not increase significantly (Fig.  1) . The individual values, however, showed a positive correlation with the relative dose of ACTH (IU/kg; this was inversely dependent on body weight) at two days (r=0-84, p<001) and one week of treatment (r=0-76, p<001). After the treatment the mean 24 hour urinary cortisol excretion fell abruptly to subnormal concentrations, 0-35 nmol/kg at one week and 0-78 nmol/kg at two weeks. The mean post-treatment serum cortisol concentrations were also significantly below the mean pretreatment concentrations. At one week after treatment the degree of this suppression showed an inverse correlation with the relative ACTH dose (r= -0-71, p<0 05).
In all infants the results of the vasopressin-ACTH test were normal before treatment (Fig. 2) . After treatment the mean maximal serum cortisol concentration in the vasopressin test was markedly reduced, with no sign of recovery by two weeks. In the ACTH test three days after treatment the mean 60 minute post-ACTH serum cortisol concentration was normal and similar to the pretreatment value. The response was abnormally short, however, and by 120 minutes post-ACTH the mean serum cortisol concentration had already decreased significantly. Of the individual infants, subnormal values occurred basally in five of the nine infants studied, at post-vasopressin maximum in two of nine, and at two hours post-ACTH in one of six. At one and two weeks after treatment even the mean 60 minute post-ACTH serum cortisol concentration was markedly reduced, indicating diminished adrenocortical responsiveness to direct stimulation. Of the individual infants at one week after treatment subnormal values occurred basally in three of six, at post-vasopressin maximum in one of six, and at two hours post-ACTH in two of four. At two weeks after treatment these numbers were two of eight, two of eight, and five of seven, respectively. A negative correlation (r=-0-80, p<001) was At two weeks the highest stimulated concentration was inversely proportional to the maximal cortisoluria during treatment. It seems that in these infants the hypercortisolism during treatment with ACTH suppresses secretion of ACTH enough to cause rapid involution of the adrenal cortex after stopping treatment with reduced ability to respond to ACTH stimulation. Another possible mechanism underlying the adrenocortical hyporesponsiveness could be desensitisation of the response effector mechanism. This seems less likely because it would be expected to peak during the height of the ACTH stimulation rather than after it as clearly happened.
In view of this subnormal response to stress some infants at least will probably be at considerable risk. 
400-n
We do not know whether further impairment occurs before recovery.
The ACTH preparation that was used had only a slightly prolonged action. In most of the infants serum cortisol concentrations were no longer raised 24 hours after the intramuscular injection. Preparations with Zn-(more) prolonged action would probably cause an even more pronounced post-treatment involution of the adrenal cortex.
From the evidence available it seems that in children the hypothalamic-pituitary-adrenocortical axis is more sensitive to suppression by treatment with pharmacological glucocorticoid than it is in adults.14 Whether this is also true of suppression by treatment with ACTH remains unknown. In any case prolonged treatment with ACTH should not be stopped abruptly. Patients undergoing such treatment should be tested for possible hypoadrenocorticism and provided with appropriate cortisol substitution until full recovery is confirmed.
